Global Oncology Precision Medicine Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Oncology Precision Medicine Industry Forecast” looks at past sales and reviews total world Oncology Precision Medicine sales in 2022, providing a comprehensive analysis by region and market sector of projected Oncology Precision Medicine sales for 2023 through 2029. With Oncology Precision Medicine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oncology Precision Medicine industry.
This Insight Report provides a comprehensive analysis of the global Oncology Precision Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oncology Precision Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oncology Precision Medicine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oncology Precision Medicine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oncology Precision Medicine.
The global Oncology Precision Medicine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Oncology Precision Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Oncology Precision Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Oncology Precision Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Oncology Precision Medicine players cover Abbott Laboratories, Agilent Technologies, Almac, ANGLE plc, Asuragen, BGI Group, Bio-Rad Laboratories, BioM?rieux and Bristol Myers Squibb, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Oncology Precision Medicine market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
LPI (LP Information)' newest research report, the “Oncology Precision Medicine Industry Forecast” looks at past sales and reviews total world Oncology Precision Medicine sales in 2022, providing a comprehensive analysis by region and market sector of projected Oncology Precision Medicine sales for 2023 through 2029. With Oncology Precision Medicine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oncology Precision Medicine industry.
This Insight Report provides a comprehensive analysis of the global Oncology Precision Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oncology Precision Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oncology Precision Medicine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oncology Precision Medicine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oncology Precision Medicine.
The global Oncology Precision Medicine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Oncology Precision Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Oncology Precision Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Oncology Precision Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Oncology Precision Medicine players cover Abbott Laboratories, Agilent Technologies, Almac, ANGLE plc, Asuragen, BGI Group, Bio-Rad Laboratories, BioM?rieux and Bristol Myers Squibb, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Oncology Precision Medicine market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Applied Sciences
- Precision Diagnostics
- Digital Health and Information Technology
- Precision Therapeutics
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Cervical Cancer
- Other Cancer
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Abbott Laboratories
- Agilent Technologies
- Almac
- ANGLE plc
- Asuragen
- BGI Group
- Bio-Rad Laboratories
- BioM?rieux
- Bristol Myers Squibb
- Roche Holding AG
- Gilead Sciences
- Illumina
- Konica Minolta
- LabCorp
- MDxHealth
- Myriad Genetics
- Novartis
- OPKO Health
- Pacific Biosciences
- Quest Diagnostics
- Qiagen
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oncology Precision Medicine Market Size 2018-2029
2.1.2 Oncology Precision Medicine Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Oncology Precision Medicine Segment by Type
2.2.1 Applied Sciences
2.2.2 Precision Diagnostics
2.2.3 Digital Health and Information Technology
2.2.4 Precision Therapeutics
2.3 Oncology Precision Medicine Market Size by Type
2.3.1 Oncology Precision Medicine Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Oncology Precision Medicine Market Size Market Share by Type (2018-2023)
2.4 Oncology Precision Medicine Segment by Application
2.4.1 Breast Cancer
2.4.2 Lung Cancer
2.4.3 Colorectal Cancer
2.4.4 Prostate Cancer
2.4.5 Cervical Cancer
2.4.6 Other Cancer
2.5 Oncology Precision Medicine Market Size by Application
2.5.1 Oncology Precision Medicine Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Oncology Precision Medicine Market Size Market Share by Application (2018-2023)
3 ONCOLOGY PRECISION MEDICINE MARKET SIZE BY PLAYER
3.1 Oncology Precision Medicine Market Size Market Share by Players
3.1.1 Global Oncology Precision Medicine Revenue by Players (2018-2023)
3.1.2 Global Oncology Precision Medicine Revenue Market Share by Players (2018-2023)
3.2 Global Oncology Precision Medicine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ONCOLOGY PRECISION MEDICINE BY REGIONS
4.1 Oncology Precision Medicine Market Size by Regions (2018-2023)
4.2 Americas Oncology Precision Medicine Market Size Growth (2018-2023)
4.3 APAC Oncology Precision Medicine Market Size Growth (2018-2023)
4.4 Europe Oncology Precision Medicine Market Size Growth (2018-2023)
4.5 Middle East & Africa Oncology Precision Medicine Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Oncology Precision Medicine Market Size by Country (2018-2023)
5.2 Americas Oncology Precision Medicine Market Size by Type (2018-2023)
5.3 Americas Oncology Precision Medicine Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oncology Precision Medicine Market Size by Region (2018-2023)
6.2 APAC Oncology Precision Medicine Market Size by Type (2018-2023)
6.3 APAC Oncology Precision Medicine Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Oncology Precision Medicine by Country (2018-2023)
7.2 Europe Oncology Precision Medicine Market Size by Type (2018-2023)
7.3 Europe Oncology Precision Medicine Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oncology Precision Medicine by Region (2018-2023)
8.2 Middle East & Africa Oncology Precision Medicine Market Size by Type (2018-2023)
8.3 Middle East & Africa Oncology Precision Medicine Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ONCOLOGY PRECISION MEDICINE MARKET FORECAST
10.1 Global Oncology Precision Medicine Forecast by Regions (2024-2029)
10.1.1 Global Oncology Precision Medicine Forecast by Regions (2024-2029)
10.1.2 Americas Oncology Precision Medicine Forecast
10.1.3 APAC Oncology Precision Medicine Forecast
10.1.4 Europe Oncology Precision Medicine Forecast
10.1.5 Middle East & Africa Oncology Precision Medicine Forecast
10.2 Americas Oncology Precision Medicine Forecast by Country (2024-2029)
10.2.1 United States Oncology Precision Medicine Market Forecast
10.2.2 Canada Oncology Precision Medicine Market Forecast
10.2.3 Mexico Oncology Precision Medicine Market Forecast
10.2.4 Brazil Oncology Precision Medicine Market Forecast
10.3 APAC Oncology Precision Medicine Forecast by Region (2024-2029)
10.3.1 China Oncology Precision Medicine Market Forecast
10.3.2 Japan Oncology Precision Medicine Market Forecast
10.3.3 Korea Oncology Precision Medicine Market Forecast
10.3.4 Southeast Asia Oncology Precision Medicine Market Forecast
10.3.5 India Oncology Precision Medicine Market Forecast
10.3.6 Australia Oncology Precision Medicine Market Forecast
10.4 Europe Oncology Precision Medicine Forecast by Country (2024-2029)
10.4.1 Germany Oncology Precision Medicine Market Forecast
10.4.2 France Oncology Precision Medicine Market Forecast
10.4.3 UK Oncology Precision Medicine Market Forecast
10.4.4 Italy Oncology Precision Medicine Market Forecast
10.4.5 Russia Oncology Precision Medicine Market Forecast
10.5 Middle East & Africa Oncology Precision Medicine Forecast by Region (2024-2029)
10.5.1 Egypt Oncology Precision Medicine Market Forecast
10.5.2 South Africa Oncology Precision Medicine Market Forecast
10.5.3 Israel Oncology Precision Medicine Market Forecast
10.5.4 Turkey Oncology Precision Medicine Market Forecast
10.5.5 GCC Countries Oncology Precision Medicine Market Forecast
10.6 Global Oncology Precision Medicine Forecast by Type (2024-2029)
10.7 Global Oncology Precision Medicine Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Information
11.1.2 Abbott Laboratories Oncology Precision Medicine Product Offered
11.1.3 Abbott Laboratories Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Abbott Laboratories Main Business Overview
11.1.5 Abbott Laboratories Latest Developments
11.2 Agilent Technologies
11.2.1 Agilent Technologies Company Information
11.2.2 Agilent Technologies Oncology Precision Medicine Product Offered
11.2.3 Agilent Technologies Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Agilent Technologies Main Business Overview
11.2.5 Agilent Technologies Latest Developments
11.3 Almac
11.3.1 Almac Company Information
11.3.2 Almac Oncology Precision Medicine Product Offered
11.3.3 Almac Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Almac Main Business Overview
11.3.5 Almac Latest Developments
11.4 ANGLE plc
11.4.1 ANGLE plc Company Information
11.4.2 ANGLE plc Oncology Precision Medicine Product Offered
11.4.3 ANGLE plc Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 ANGLE plc Main Business Overview
11.4.5 ANGLE plc Latest Developments
11.5 Asuragen
11.5.1 Asuragen Company Information
11.5.2 Asuragen Oncology Precision Medicine Product Offered
11.5.3 Asuragen Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Asuragen Main Business Overview
11.5.5 Asuragen Latest Developments
11.6 BGI Group
11.6.1 BGI Group Company Information
11.6.2 BGI Group Oncology Precision Medicine Product Offered
11.6.3 BGI Group Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 BGI Group Main Business Overview
11.6.5 BGI Group Latest Developments
11.7 Bio-Rad Laboratories
11.7.1 Bio-Rad Laboratories Company Information
11.7.2 Bio-Rad Laboratories Oncology Precision Medicine Product Offered
11.7.3 Bio-Rad Laboratories Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Bio-Rad Laboratories Main Business Overview
11.7.5 Bio-Rad Laboratories Latest Developments
11.8 BioM?rieux
11.8.1 BioM?rieux Company Information
11.8.2 BioM?rieux Oncology Precision Medicine Product Offered
11.8.3 BioM?rieux Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 BioM?rieux Main Business Overview
11.8.5 BioM?rieux Latest Developments
11.9 Bristol Myers Squibb
11.9.1 Bristol Myers Squibb Company Information
11.9.2 Bristol Myers Squibb Oncology Precision Medicine Product Offered
11.9.3 Bristol Myers Squibb Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Bristol Myers Squibb Main Business Overview
11.9.5 Bristol Myers Squibb Latest Developments
11.10 Roche Holding AG
11.10.1 Roche Holding AG Company Information
11.10.2 Roche Holding AG Oncology Precision Medicine Product Offered
11.10.3 Roche Holding AG Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Roche Holding AG Main Business Overview
11.10.5 Roche Holding AG Latest Developments
11.11 Gilead Sciences
11.11.1 Gilead Sciences Company Information
11.11.2 Gilead Sciences Oncology Precision Medicine Product Offered
11.11.3 Gilead Sciences Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Gilead Sciences Main Business Overview
11.11.5 Gilead Sciences Latest Developments
11.12 Illumina
11.12.1 Illumina Company Information
11.12.2 Illumina Oncology Precision Medicine Product Offered
11.12.3 Illumina Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Illumina Main Business Overview
11.12.5 Illumina Latest Developments
11.13 Konica Minolta
11.13.1 Konica Minolta Company Information
11.13.2 Konica Minolta Oncology Precision Medicine Product Offered
11.13.3 Konica Minolta Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Konica Minolta Main Business Overview
11.13.5 Konica Minolta Latest Developments
11.14 LabCorp
11.14.1 LabCorp Company Information
11.14.2 LabCorp Oncology Precision Medicine Product Offered
11.14.3 LabCorp Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 LabCorp Main Business Overview
11.14.5 LabCorp Latest Developments
11.15 MDxHealth
11.15.1 MDxHealth Company Information
11.15.2 MDxHealth Oncology Precision Medicine Product Offered
11.15.3 MDxHealth Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 MDxHealth Main Business Overview
11.15.5 MDxHealth Latest Developments
11.16 Myriad Genetics
11.16.1 Myriad Genetics Company Information
11.16.2 Myriad Genetics Oncology Precision Medicine Product Offered
11.16.3 Myriad Genetics Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Myriad Genetics Main Business Overview
11.16.5 Myriad Genetics Latest Developments
11.17 Novartis
11.17.1 Novartis Company Information
11.17.2 Novartis Oncology Precision Medicine Product Offered
11.17.3 Novartis Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 Novartis Main Business Overview
11.17.5 Novartis Latest Developments
11.18 OPKO Health
11.18.1 OPKO Health Company Information
11.18.2 OPKO Health Oncology Precision Medicine Product Offered
11.18.3 OPKO Health Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 OPKO Health Main Business Overview
11.18.5 OPKO Health Latest Developments
11.19 Pacific Biosciences
11.19.1 Pacific Biosciences Company Information
11.19.2 Pacific Biosciences Oncology Precision Medicine Product Offered
11.19.3 Pacific Biosciences Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.19.4 Pacific Biosciences Main Business Overview
11.19.5 Pacific Biosciences Latest Developments
11.20 Quest Diagnostics
11.20.1 Quest Diagnostics Company Information
11.20.2 Quest Diagnostics Oncology Precision Medicine Product Offered
11.20.3 Quest Diagnostics Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.20.4 Quest Diagnostics Main Business Overview
11.20.5 Quest Diagnostics Latest Developments
11.21 Qiagen
11.21.1 Qiagen Company Information
11.21.2 Qiagen Oncology Precision Medicine Product Offered
11.21.3 Qiagen Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.21.4 Qiagen Main Business Overview
11.21.5 Qiagen Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oncology Precision Medicine Market Size 2018-2029
2.1.2 Oncology Precision Medicine Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Oncology Precision Medicine Segment by Type
2.2.1 Applied Sciences
2.2.2 Precision Diagnostics
2.2.3 Digital Health and Information Technology
2.2.4 Precision Therapeutics
2.3 Oncology Precision Medicine Market Size by Type
2.3.1 Oncology Precision Medicine Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Oncology Precision Medicine Market Size Market Share by Type (2018-2023)
2.4 Oncology Precision Medicine Segment by Application
2.4.1 Breast Cancer
2.4.2 Lung Cancer
2.4.3 Colorectal Cancer
2.4.4 Prostate Cancer
2.4.5 Cervical Cancer
2.4.6 Other Cancer
2.5 Oncology Precision Medicine Market Size by Application
2.5.1 Oncology Precision Medicine Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Oncology Precision Medicine Market Size Market Share by Application (2018-2023)
3 ONCOLOGY PRECISION MEDICINE MARKET SIZE BY PLAYER
3.1 Oncology Precision Medicine Market Size Market Share by Players
3.1.1 Global Oncology Precision Medicine Revenue by Players (2018-2023)
3.1.2 Global Oncology Precision Medicine Revenue Market Share by Players (2018-2023)
3.2 Global Oncology Precision Medicine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ONCOLOGY PRECISION MEDICINE BY REGIONS
4.1 Oncology Precision Medicine Market Size by Regions (2018-2023)
4.2 Americas Oncology Precision Medicine Market Size Growth (2018-2023)
4.3 APAC Oncology Precision Medicine Market Size Growth (2018-2023)
4.4 Europe Oncology Precision Medicine Market Size Growth (2018-2023)
4.5 Middle East & Africa Oncology Precision Medicine Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Oncology Precision Medicine Market Size by Country (2018-2023)
5.2 Americas Oncology Precision Medicine Market Size by Type (2018-2023)
5.3 Americas Oncology Precision Medicine Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oncology Precision Medicine Market Size by Region (2018-2023)
6.2 APAC Oncology Precision Medicine Market Size by Type (2018-2023)
6.3 APAC Oncology Precision Medicine Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Oncology Precision Medicine by Country (2018-2023)
7.2 Europe Oncology Precision Medicine Market Size by Type (2018-2023)
7.3 Europe Oncology Precision Medicine Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oncology Precision Medicine by Region (2018-2023)
8.2 Middle East & Africa Oncology Precision Medicine Market Size by Type (2018-2023)
8.3 Middle East & Africa Oncology Precision Medicine Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ONCOLOGY PRECISION MEDICINE MARKET FORECAST
10.1 Global Oncology Precision Medicine Forecast by Regions (2024-2029)
10.1.1 Global Oncology Precision Medicine Forecast by Regions (2024-2029)
10.1.2 Americas Oncology Precision Medicine Forecast
10.1.3 APAC Oncology Precision Medicine Forecast
10.1.4 Europe Oncology Precision Medicine Forecast
10.1.5 Middle East & Africa Oncology Precision Medicine Forecast
10.2 Americas Oncology Precision Medicine Forecast by Country (2024-2029)
10.2.1 United States Oncology Precision Medicine Market Forecast
10.2.2 Canada Oncology Precision Medicine Market Forecast
10.2.3 Mexico Oncology Precision Medicine Market Forecast
10.2.4 Brazil Oncology Precision Medicine Market Forecast
10.3 APAC Oncology Precision Medicine Forecast by Region (2024-2029)
10.3.1 China Oncology Precision Medicine Market Forecast
10.3.2 Japan Oncology Precision Medicine Market Forecast
10.3.3 Korea Oncology Precision Medicine Market Forecast
10.3.4 Southeast Asia Oncology Precision Medicine Market Forecast
10.3.5 India Oncology Precision Medicine Market Forecast
10.3.6 Australia Oncology Precision Medicine Market Forecast
10.4 Europe Oncology Precision Medicine Forecast by Country (2024-2029)
10.4.1 Germany Oncology Precision Medicine Market Forecast
10.4.2 France Oncology Precision Medicine Market Forecast
10.4.3 UK Oncology Precision Medicine Market Forecast
10.4.4 Italy Oncology Precision Medicine Market Forecast
10.4.5 Russia Oncology Precision Medicine Market Forecast
10.5 Middle East & Africa Oncology Precision Medicine Forecast by Region (2024-2029)
10.5.1 Egypt Oncology Precision Medicine Market Forecast
10.5.2 South Africa Oncology Precision Medicine Market Forecast
10.5.3 Israel Oncology Precision Medicine Market Forecast
10.5.4 Turkey Oncology Precision Medicine Market Forecast
10.5.5 GCC Countries Oncology Precision Medicine Market Forecast
10.6 Global Oncology Precision Medicine Forecast by Type (2024-2029)
10.7 Global Oncology Precision Medicine Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Information
11.1.2 Abbott Laboratories Oncology Precision Medicine Product Offered
11.1.3 Abbott Laboratories Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Abbott Laboratories Main Business Overview
11.1.5 Abbott Laboratories Latest Developments
11.2 Agilent Technologies
11.2.1 Agilent Technologies Company Information
11.2.2 Agilent Technologies Oncology Precision Medicine Product Offered
11.2.3 Agilent Technologies Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Agilent Technologies Main Business Overview
11.2.5 Agilent Technologies Latest Developments
11.3 Almac
11.3.1 Almac Company Information
11.3.2 Almac Oncology Precision Medicine Product Offered
11.3.3 Almac Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Almac Main Business Overview
11.3.5 Almac Latest Developments
11.4 ANGLE plc
11.4.1 ANGLE plc Company Information
11.4.2 ANGLE plc Oncology Precision Medicine Product Offered
11.4.3 ANGLE plc Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 ANGLE plc Main Business Overview
11.4.5 ANGLE plc Latest Developments
11.5 Asuragen
11.5.1 Asuragen Company Information
11.5.2 Asuragen Oncology Precision Medicine Product Offered
11.5.3 Asuragen Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Asuragen Main Business Overview
11.5.5 Asuragen Latest Developments
11.6 BGI Group
11.6.1 BGI Group Company Information
11.6.2 BGI Group Oncology Precision Medicine Product Offered
11.6.3 BGI Group Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 BGI Group Main Business Overview
11.6.5 BGI Group Latest Developments
11.7 Bio-Rad Laboratories
11.7.1 Bio-Rad Laboratories Company Information
11.7.2 Bio-Rad Laboratories Oncology Precision Medicine Product Offered
11.7.3 Bio-Rad Laboratories Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Bio-Rad Laboratories Main Business Overview
11.7.5 Bio-Rad Laboratories Latest Developments
11.8 BioM?rieux
11.8.1 BioM?rieux Company Information
11.8.2 BioM?rieux Oncology Precision Medicine Product Offered
11.8.3 BioM?rieux Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 BioM?rieux Main Business Overview
11.8.5 BioM?rieux Latest Developments
11.9 Bristol Myers Squibb
11.9.1 Bristol Myers Squibb Company Information
11.9.2 Bristol Myers Squibb Oncology Precision Medicine Product Offered
11.9.3 Bristol Myers Squibb Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Bristol Myers Squibb Main Business Overview
11.9.5 Bristol Myers Squibb Latest Developments
11.10 Roche Holding AG
11.10.1 Roche Holding AG Company Information
11.10.2 Roche Holding AG Oncology Precision Medicine Product Offered
11.10.3 Roche Holding AG Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Roche Holding AG Main Business Overview
11.10.5 Roche Holding AG Latest Developments
11.11 Gilead Sciences
11.11.1 Gilead Sciences Company Information
11.11.2 Gilead Sciences Oncology Precision Medicine Product Offered
11.11.3 Gilead Sciences Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Gilead Sciences Main Business Overview
11.11.5 Gilead Sciences Latest Developments
11.12 Illumina
11.12.1 Illumina Company Information
11.12.2 Illumina Oncology Precision Medicine Product Offered
11.12.3 Illumina Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Illumina Main Business Overview
11.12.5 Illumina Latest Developments
11.13 Konica Minolta
11.13.1 Konica Minolta Company Information
11.13.2 Konica Minolta Oncology Precision Medicine Product Offered
11.13.3 Konica Minolta Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Konica Minolta Main Business Overview
11.13.5 Konica Minolta Latest Developments
11.14 LabCorp
11.14.1 LabCorp Company Information
11.14.2 LabCorp Oncology Precision Medicine Product Offered
11.14.3 LabCorp Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 LabCorp Main Business Overview
11.14.5 LabCorp Latest Developments
11.15 MDxHealth
11.15.1 MDxHealth Company Information
11.15.2 MDxHealth Oncology Precision Medicine Product Offered
11.15.3 MDxHealth Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 MDxHealth Main Business Overview
11.15.5 MDxHealth Latest Developments
11.16 Myriad Genetics
11.16.1 Myriad Genetics Company Information
11.16.2 Myriad Genetics Oncology Precision Medicine Product Offered
11.16.3 Myriad Genetics Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Myriad Genetics Main Business Overview
11.16.5 Myriad Genetics Latest Developments
11.17 Novartis
11.17.1 Novartis Company Information
11.17.2 Novartis Oncology Precision Medicine Product Offered
11.17.3 Novartis Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 Novartis Main Business Overview
11.17.5 Novartis Latest Developments
11.18 OPKO Health
11.18.1 OPKO Health Company Information
11.18.2 OPKO Health Oncology Precision Medicine Product Offered
11.18.3 OPKO Health Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 OPKO Health Main Business Overview
11.18.5 OPKO Health Latest Developments
11.19 Pacific Biosciences
11.19.1 Pacific Biosciences Company Information
11.19.2 Pacific Biosciences Oncology Precision Medicine Product Offered
11.19.3 Pacific Biosciences Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.19.4 Pacific Biosciences Main Business Overview
11.19.5 Pacific Biosciences Latest Developments
11.20 Quest Diagnostics
11.20.1 Quest Diagnostics Company Information
11.20.2 Quest Diagnostics Oncology Precision Medicine Product Offered
11.20.3 Quest Diagnostics Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.20.4 Quest Diagnostics Main Business Overview
11.20.5 Quest Diagnostics Latest Developments
11.21 Qiagen
11.21.1 Qiagen Company Information
11.21.2 Qiagen Oncology Precision Medicine Product Offered
11.21.3 Qiagen Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.21.4 Qiagen Main Business Overview
11.21.5 Qiagen Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Oncology Precision Medicine Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Applied Sciences
Table 3. Major Players of Precision Diagnostics
Table 4. Major Players of Digital Health and Information Technology
Table 5. Major Players of Precision Therapeutics
Table 6. Oncology Precision Medicine Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 7. Global Oncology Precision Medicine Market Size by Type (2018-2023) & ($ Millions)
Table 8. Global Oncology Precision Medicine Market Size Market Share by Type (2018-2023)
Table 9. Oncology Precision Medicine Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Oncology Precision Medicine Market Size by Application (2018-2023) & ($ Millions)
Table 11. Global Oncology Precision Medicine Market Size Market Share by Application (2018-2023)
Table 12. Global Oncology Precision Medicine Revenue by Players (2018-2023) & ($ Millions)
Table 13. Global Oncology Precision Medicine Revenue Market Share by Player (2018-2023)
Table 14. Oncology Precision Medicine Key Players Head office and Products Offered
Table 15. Oncology Precision Medicine Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Oncology Precision Medicine Market Size by Regions 2018-2023 & ($ Millions)
Table 19. Global Oncology Precision Medicine Market Size Market Share by Regions (2018-2023)
Table 20. Global Oncology Precision Medicine Revenue by Country/Region (2018-2023) & ($ millions)
Table 21. Global Oncology Precision Medicine Revenue Market Share by Country/Region (2018-2023)
Table 22. Americas Oncology Precision Medicine Market Size by Country (2018-2023) & ($ Millions)
Table 23. Americas Oncology Precision Medicine Market Size Market Share by Country (2018-2023)
Table 24. Americas Oncology Precision Medicine Market Size by Type (2018-2023) & ($ Millions)
Table 25. Americas Oncology Precision Medicine Market Size Market Share by Type (2018-2023)
Table 26. Americas Oncology Precision Medicine Market Size by Application (2018-2023) & ($ Millions)
Table 27. Americas Oncology Precision Medicine Market Size Market Share by Application (2018-2023)
Table 28. APAC Oncology Precision Medicine Market Size by Region (2018-2023) & ($ Millions)
Table 29. APAC Oncology Precision Medicine Market Size Market Share by Region (2018-2023)
Table 30. APAC Oncology Precision Medicine Market Size by Type (2018-2023) & ($ Millions)
Table 31. APAC Oncology Precision Medicine Market Size Market Share by Type (2018-2023)
Table 32. APAC Oncology Precision Medicine Market Size by Application (2018-2023) & ($ Millions)
Table 33. APAC Oncology Precision Medicine Market Size Market Share by Application (2018-2023)
Table 34. Europe Oncology Precision Medicine Market Size by Country (2018-2023) & ($ Millions)
Table 35. Europe Oncology Precision Medicine Market Size Market Share by Country (2018-2023)
Table 36. Europe Oncology Precision Medicine Market Size by Type (2018-2023) & ($ Millions)
Table 37. Europe Oncology Precision Medicine Market Size Market Share by Type (2018-2023)
Table 38. Europe Oncology Precision Medicine Market Size by Application (2018-2023) & ($ Millions)
Table 39. Europe Oncology Precision Medicine Market Size Market Share by Application (2018-2023)
Table 40. Middle East & Africa Oncology Precision Medicine Market Size by Region (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Oncology Precision Medicine Market Size Market Share by Region (2018-2023)
Table 42. Middle East & Africa Oncology Precision Medicine Market Size by Type (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Oncology Precision Medicine Market Size Market Share by Type (2018-2023)
Table 44. Middle East & Africa Oncology Precision Medicine Market Size by Application (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Oncology Precision Medicine Market Size Market Share by Application (2018-2023)
Table 46. Key Market Drivers & Growth Opportunities of Oncology Precision Medicine
Table 47. Key Market Challenges & Risks of Oncology Precision Medicine
Table 48. Key Industry Trends of Oncology Precision Medicine
Table 49. Global Oncology Precision Medicine Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 50. Global Oncology Precision Medicine Market Size Market Share Forecast by Regions (2024-2029)
Table 51. Global Oncology Precision Medicine Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 52. Global Oncology Precision Medicine Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 53. Abbott Laboratories Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors
Table 54. Abbott Laboratories Oncology Precision Medicine Product Offered
Table 55. Abbott Laboratories Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 56. Abbott Laboratories Main Business
Table 57. Abbott Laboratories Latest Developments
Table 58. Agilent Technologies Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors
Table 59. Agilent Technologies Oncology Precision Medicine Product Offered
Table 60. Agilent Technologies Main Business
Table 61. Agilent Technologies Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. Agilent Technologies Latest Developments
Table 63. Almac Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors
Table 64. Almac Oncology Precision Medicine Product Offered
Table 65. Almac Main Business
Table 66. Almac Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. Almac Latest Developments
Table 68. ANGLE plc Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors
Table 69. ANGLE plc Oncology Precision Medicine Product Offered
Table 70. ANGLE plc Main Business
Table 71. ANGLE plc Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. ANGLE plc Latest Developments
Table 73. Asuragen Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors
Table 74. Asuragen Oncology Precision Medicine Product Offered
Table 75. Asuragen Main Business
Table 76. Asuragen Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 77. Asuragen Latest Developments
Table 78. BGI Group Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors
Table 79. BGI Group Oncology Precision Medicine Product Offered
Table 80. BGI Group Main Business
Table 81. BGI Group Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 82. BGI Group Latest Developments
Table 83. Bio-Rad Laboratories Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors
Table 84. Bio-Rad Laboratories Oncology Precision Medicine Product Offered
Table 85. Bio-Rad Laboratories Main Business
Table 86. Bio-Rad Laboratories Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 87. Bio-Rad Laboratories Latest Developments
Table 88. BioM?rieux Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors
Table 89. BioM?rieux Oncology Precision Medicine Product Offered
Table 90. BioM?rieux Main Business
Table 91. BioM?rieux Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 92. BioM?rieux Latest Developments
Table 93. Bristol Myers Squibb Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors
Table 94. Bristol Myers Squibb Oncology Precision Medicine Product Offered
Table 95. Bristol Myers Squibb Main Business
Table 96. Bristol Myers Squibb Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 97. Bristol Myers Squibb Latest Developments
Table 98. Roche Holding AG Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors
Table 99. Roche Holding AG Oncology Precision Medicine Product Offered
Table 100. Roche Holding AG Main Business
Table 101. Roche Holding AG Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 102. Roche Holding AG Latest Developments
Table 103. Gilead Sciences Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors
Table 104. Gilead Sciences Oncology Precision Medicine Product Offered
Table 105. Gilead Sciences Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 106. Gilead Sciences Main Business
Table 107. Gilead Sciences Latest Developments
Table 108. Illumina Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors
Table 109. Illumina Oncology Precision Medicine Product Offered
Table 110. Illumina Main Business
Table 111. Illumina Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 112. Illumina Latest Developments
Table 113. Konica Minolta Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors
Table 114. Konica Minolta Oncology Precision Medicine Product Offered
Table 115. Konica Minolta Main Business
Table 116. Konica Minolta Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 117. Konica Minolta Latest Developments
Table 118. LabCorp Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors
Table 119. LabCorp Oncology Precision Medicine Product Offered
Table 120. LabCorp Main Business
Table 121. LabCorp Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 122. LabCorp Latest Developments
Table 123. MDxHealth Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors
Table 124. MDxHealth Oncology Precision Medicine Product Offered
Table 125. MDxHealth Main Business
Table 126. MDxHealth Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 127. MDxHealth Latest Developments
Table 128. Myriad Genetics Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors
Table 129. Myriad Genetics Oncology Precision Medicine Product Offered
Table 130. Myriad Genetics Main Business
Table 131. Myriad Genetics Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 132. Myriad Genetics Latest Developments
Table 133. Novartis Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors
Table 134. Novartis Oncology Precision Medicine Product Offered
Table 135. Novartis Main Business
Table 136. Novartis Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 137. Novartis Latest Developments
Table 138. OPKO Health Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors
Table 139. OPKO Health Oncology Precision Medicine Product Offered
Table 140. OPKO Health Main Business
Table 141. OPKO Health Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 142. OPKO Health Latest Developments
Table 143. Pacific Biosciences Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors
Table 144. Pacific Biosciences Oncology Precision Medicine Product Offered
Table 145. Pacific Biosciences Main Business
Table 146. Pacific Biosciences Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 147. Pacific Biosciences Latest Developments
Table 148. Quest Diagnostics Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors
Table 149. Quest Diagnostics Oncology Precision Medicine Product Offered
Table 150. Quest Diagnostics Main Business
Table 151. Quest Diagnostics Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 152. Quest Diagnostics Latest Developments
Table 153. Qiagen Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors
Table 154. Qiagen Oncology Precision Medicine Product Offered
Table 155. Qiagen Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 156. Qiagen Main Business
Table 157. Qiagen Latest Developments
Table 1. Oncology Precision Medicine Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Applied Sciences
Table 3. Major Players of Precision Diagnostics
Table 4. Major Players of Digital Health and Information Technology
Table 5. Major Players of Precision Therapeutics
Table 6. Oncology Precision Medicine Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 7. Global Oncology Precision Medicine Market Size by Type (2018-2023) & ($ Millions)
Table 8. Global Oncology Precision Medicine Market Size Market Share by Type (2018-2023)
Table 9. Oncology Precision Medicine Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Oncology Precision Medicine Market Size by Application (2018-2023) & ($ Millions)
Table 11. Global Oncology Precision Medicine Market Size Market Share by Application (2018-2023)
Table 12. Global Oncology Precision Medicine Revenue by Players (2018-2023) & ($ Millions)
Table 13. Global Oncology Precision Medicine Revenue Market Share by Player (2018-2023)
Table 14. Oncology Precision Medicine Key Players Head office and Products Offered
Table 15. Oncology Precision Medicine Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Oncology Precision Medicine Market Size by Regions 2018-2023 & ($ Millions)
Table 19. Global Oncology Precision Medicine Market Size Market Share by Regions (2018-2023)
Table 20. Global Oncology Precision Medicine Revenue by Country/Region (2018-2023) & ($ millions)
Table 21. Global Oncology Precision Medicine Revenue Market Share by Country/Region (2018-2023)
Table 22. Americas Oncology Precision Medicine Market Size by Country (2018-2023) & ($ Millions)
Table 23. Americas Oncology Precision Medicine Market Size Market Share by Country (2018-2023)
Table 24. Americas Oncology Precision Medicine Market Size by Type (2018-2023) & ($ Millions)
Table 25. Americas Oncology Precision Medicine Market Size Market Share by Type (2018-2023)
Table 26. Americas Oncology Precision Medicine Market Size by Application (2018-2023) & ($ Millions)
Table 27. Americas Oncology Precision Medicine Market Size Market Share by Application (2018-2023)
Table 28. APAC Oncology Precision Medicine Market Size by Region (2018-2023) & ($ Millions)
Table 29. APAC Oncology Precision Medicine Market Size Market Share by Region (2018-2023)
Table 30. APAC Oncology Precision Medicine Market Size by Type (2018-2023) & ($ Millions)
Table 31. APAC Oncology Precision Medicine Market Size Market Share by Type (2018-2023)
Table 32. APAC Oncology Precision Medicine Market Size by Application (2018-2023) & ($ Millions)
Table 33. APAC Oncology Precision Medicine Market Size Market Share by Application (2018-2023)
Table 34. Europe Oncology Precision Medicine Market Size by Country (2018-2023) & ($ Millions)
Table 35. Europe Oncology Precision Medicine Market Size Market Share by Country (2018-2023)
Table 36. Europe Oncology Precision Medicine Market Size by Type (2018-2023) & ($ Millions)
Table 37. Europe Oncology Precision Medicine Market Size Market Share by Type (2018-2023)
Table 38. Europe Oncology Precision Medicine Market Size by Application (2018-2023) & ($ Millions)
Table 39. Europe Oncology Precision Medicine Market Size Market Share by Application (2018-2023)
Table 40. Middle East & Africa Oncology Precision Medicine Market Size by Region (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Oncology Precision Medicine Market Size Market Share by Region (2018-2023)
Table 42. Middle East & Africa Oncology Precision Medicine Market Size by Type (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Oncology Precision Medicine Market Size Market Share by Type (2018-2023)
Table 44. Middle East & Africa Oncology Precision Medicine Market Size by Application (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Oncology Precision Medicine Market Size Market Share by Application (2018-2023)
Table 46. Key Market Drivers & Growth Opportunities of Oncology Precision Medicine
Table 47. Key Market Challenges & Risks of Oncology Precision Medicine
Table 48. Key Industry Trends of Oncology Precision Medicine
Table 49. Global Oncology Precision Medicine Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 50. Global Oncology Precision Medicine Market Size Market Share Forecast by Regions (2024-2029)
Table 51. Global Oncology Precision Medicine Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 52. Global Oncology Precision Medicine Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 53. Abbott Laboratories Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors
Table 54. Abbott Laboratories Oncology Precision Medicine Product Offered
Table 55. Abbott Laboratories Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 56. Abbott Laboratories Main Business
Table 57. Abbott Laboratories Latest Developments
Table 58. Agilent Technologies Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors
Table 59. Agilent Technologies Oncology Precision Medicine Product Offered
Table 60. Agilent Technologies Main Business
Table 61. Agilent Technologies Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. Agilent Technologies Latest Developments
Table 63. Almac Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors
Table 64. Almac Oncology Precision Medicine Product Offered
Table 65. Almac Main Business
Table 66. Almac Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. Almac Latest Developments
Table 68. ANGLE plc Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors
Table 69. ANGLE plc Oncology Precision Medicine Product Offered
Table 70. ANGLE plc Main Business
Table 71. ANGLE plc Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. ANGLE plc Latest Developments
Table 73. Asuragen Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors
Table 74. Asuragen Oncology Precision Medicine Product Offered
Table 75. Asuragen Main Business
Table 76. Asuragen Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 77. Asuragen Latest Developments
Table 78. BGI Group Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors
Table 79. BGI Group Oncology Precision Medicine Product Offered
Table 80. BGI Group Main Business
Table 81. BGI Group Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 82. BGI Group Latest Developments
Table 83. Bio-Rad Laboratories Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors
Table 84. Bio-Rad Laboratories Oncology Precision Medicine Product Offered
Table 85. Bio-Rad Laboratories Main Business
Table 86. Bio-Rad Laboratories Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 87. Bio-Rad Laboratories Latest Developments
Table 88. BioM?rieux Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors
Table 89. BioM?rieux Oncology Precision Medicine Product Offered
Table 90. BioM?rieux Main Business
Table 91. BioM?rieux Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 92. BioM?rieux Latest Developments
Table 93. Bristol Myers Squibb Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors
Table 94. Bristol Myers Squibb Oncology Precision Medicine Product Offered
Table 95. Bristol Myers Squibb Main Business
Table 96. Bristol Myers Squibb Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 97. Bristol Myers Squibb Latest Developments
Table 98. Roche Holding AG Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors
Table 99. Roche Holding AG Oncology Precision Medicine Product Offered
Table 100. Roche Holding AG Main Business
Table 101. Roche Holding AG Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 102. Roche Holding AG Latest Developments
Table 103. Gilead Sciences Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors
Table 104. Gilead Sciences Oncology Precision Medicine Product Offered
Table 105. Gilead Sciences Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 106. Gilead Sciences Main Business
Table 107. Gilead Sciences Latest Developments
Table 108. Illumina Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors
Table 109. Illumina Oncology Precision Medicine Product Offered
Table 110. Illumina Main Business
Table 111. Illumina Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 112. Illumina Latest Developments
Table 113. Konica Minolta Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors
Table 114. Konica Minolta Oncology Precision Medicine Product Offered
Table 115. Konica Minolta Main Business
Table 116. Konica Minolta Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 117. Konica Minolta Latest Developments
Table 118. LabCorp Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors
Table 119. LabCorp Oncology Precision Medicine Product Offered
Table 120. LabCorp Main Business
Table 121. LabCorp Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 122. LabCorp Latest Developments
Table 123. MDxHealth Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors
Table 124. MDxHealth Oncology Precision Medicine Product Offered
Table 125. MDxHealth Main Business
Table 126. MDxHealth Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 127. MDxHealth Latest Developments
Table 128. Myriad Genetics Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors
Table 129. Myriad Genetics Oncology Precision Medicine Product Offered
Table 130. Myriad Genetics Main Business
Table 131. Myriad Genetics Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 132. Myriad Genetics Latest Developments
Table 133. Novartis Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors
Table 134. Novartis Oncology Precision Medicine Product Offered
Table 135. Novartis Main Business
Table 136. Novartis Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 137. Novartis Latest Developments
Table 138. OPKO Health Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors
Table 139. OPKO Health Oncology Precision Medicine Product Offered
Table 140. OPKO Health Main Business
Table 141. OPKO Health Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 142. OPKO Health Latest Developments
Table 143. Pacific Biosciences Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors
Table 144. Pacific Biosciences Oncology Precision Medicine Product Offered
Table 145. Pacific Biosciences Main Business
Table 146. Pacific Biosciences Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 147. Pacific Biosciences Latest Developments
Table 148. Quest Diagnostics Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors
Table 149. Quest Diagnostics Oncology Precision Medicine Product Offered
Table 150. Quest Diagnostics Main Business
Table 151. Quest Diagnostics Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 152. Quest Diagnostics Latest Developments
Table 153. Qiagen Details, Company Type, Oncology Precision Medicine Area Served and Its Competitors
Table 154. Qiagen Oncology Precision Medicine Product Offered
Table 155. Qiagen Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 156. Qiagen Main Business
Table 157. Qiagen Latest Developments
LIST OF FIGURES
Figure 1. Oncology Precision Medicine Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Oncology Precision Medicine Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Oncology Precision Medicine Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Oncology Precision Medicine Sales Market Share by Country/Region (2022)
Figure 8. Oncology Precision Medicine Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Oncology Precision Medicine Market Size Market Share by Type in 2022
Figure 10. Oncology Precision Medicine in Breast Cancer
Figure 11. Global Oncology Precision Medicine Market: Breast Cancer (2018-2023) & ($ Millions)
Figure 12. Oncology Precision Medicine in Lung Cancer
Figure 13. Global Oncology Precision Medicine Market: Lung Cancer (2018-2023) & ($ Millions)
Figure 14. Oncology Precision Medicine in Colorectal Cancer
Figure 15. Global Oncology Precision Medicine Market: Colorectal Cancer (2018-2023) & ($ Millions)
Figure 16. Oncology Precision Medicine in Prostate Cancer
Figure 17. Global Oncology Precision Medicine Market: Prostate Cancer (2018-2023) & ($ Millions)
Figure 18. Oncology Precision Medicine in Cervical Cancer
Figure 19. Global Oncology Precision Medicine Market: Cervical Cancer (2018-2023) & ($ Millions)
Figure 20. Oncology Precision Medicine in Other Cancer
Figure 21. Global Oncology Precision Medicine Market: Other Cancer (2018-2023) & ($ Millions)
Figure 22. Global Oncology Precision Medicine Market Size Market Share by Application in 2022
Figure 23. Global Oncology Precision Medicine Revenue Market Share by Player in 2022
Figure 24. Global Oncology Precision Medicine Market Size Market Share by Regions (2018-2023)
Figure 25. Americas Oncology Precision Medicine Market Size 2018-2023 ($ Millions)
Figure 26. APAC Oncology Precision Medicine Market Size 2018-2023 ($ Millions)
Figure 27. Europe Oncology Precision Medicine Market Size 2018-2023 ($ Millions)
Figure 28. Middle East & Africa Oncology Precision Medicine Market Size 2018-2023 ($ Millions)
Figure 29. Americas Oncology Precision Medicine Value Market Share by Country in 2022
Figure 30. United States Oncology Precision Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 31. Canada Oncology Precision Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 32. Mexico Oncology Precision Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 33. Brazil Oncology Precision Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 34. APAC Oncology Precision Medicine Market Size Market Share by Region in 2022
Figure 35. APAC Oncology Precision Medicine Market Size Market Share by Type in 2022
Figure 36. APAC Oncology Precision Medicine Market Size Market Share by Application in 2022
Figure 37. China Oncology Precision Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 38. Japan Oncology Precision Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 39. Korea Oncology Precision Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 40. Southeast Asia Oncology Precision Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 41. India Oncology Precision Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 42. Australia Oncology Precision Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 43. Europe Oncology Precision Medicine Market Size Market Share by Country in 2022
Figure 44. Europe Oncology Precision Medicine Market Size Market Share by Type (2018-2023)
Figure 45. Europe Oncology Precision Medicine Market Size Market Share by Application (2018-2023)
Figure 46. Germany Oncology Precision Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 47. France Oncology Precision Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 48. UK Oncology Precision Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 49. Italy Oncology Precision Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 50. Russia Oncology Precision Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 51. Middle East & Africa Oncology Precision Medicine Market Size Market Share by Region (2018-2023)
Figure 52. Middle East & Africa Oncology Precision Medicine Market Size Market Share by Type (2018-2023)
Figure 53. Middle East & Africa Oncology Precision Medicine Market Size Market Share by Application (2018-2023)
Figure 54. Egypt Oncology Precision Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 55. South Africa Oncology Precision Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 56. Israel Oncology Precision Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 57. Turkey Oncology Precision Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 58. GCC Country Oncology Precision Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 59. Americas Oncology Precision Medicine Market Size 2024-2029 ($ Millions)
Figure 60. APAC Oncology Precision Medicine Market Size 2024-2029 ($ Millions)
Figure 61. Europe Oncology Precision Medicine Market Size 2024-2029 ($ Millions)
Figure 62. Middle East & Africa Oncology Precision Medicine Market Size 2024-2029 ($ Millions)
Figure 63. United States Oncology Precision Medicine Market Size 2024-2029 ($ Millions)
Figure 64. Canada Oncology Precision Medicine Market Size 2024-2029 ($ Millions)
Figure 65. Mexico Oncology Precision Medicine Market Size 2024-2029 ($ Millions)
Figure 66. Brazil Oncology Precision Medicine Market Size 2024-2029 ($ Millions)
Figure 67. China Oncology Precision Medicine Market Size 2024-2029 ($ Millions)
Figure 68. Japan Oncology Precision Medicine Market Size 2024-2029 ($ Millions)
Figure 69. Korea Oncology Precision Medicine Market Size 2024-2029 ($ Millions)
Figure 70. Southeast Asia Oncology Precision Medicine Market Size 2024-2029 ($ Millions)
Figure 71. India Oncology Precision Medicine Market Size 2024-2029 ($ Millions)
Figure 72. Australia Oncology Precision Medicine Market Size 2024-2029 ($ Millions)
Figure 73. Germany Oncology Precision Medicine Market Size 2024-2029 ($ Millions)
Figure 74. France Oncology Precision Medicine Market Size 2024-2029 ($ Millions)
Figure 75. UK Oncology Precision Medicine Market Size 2024-2029 ($ Millions)
Figure 76. Italy Oncology Precision Medicine Market Size 2024-2029 ($ Millions)
Figure 77. Russia Oncology Precision Medicine Market Size 2024-2029 ($ Millions)
Figure 78. Spain Oncology Precision Medicine Market Size 2024-2029 ($ Millions)
Figure 79. Egypt Oncology Precision Medicine Market Size 2024-2029 ($ Millions)
Figure 80. South Africa Oncology Precision Medicine Market Size 2024-2029 ($ Millions)
Figure 81. Israel Oncology Precision Medicine Market Size 2024-2029 ($ Millions)
Figure 82. Turkey Oncology Precision Medicine Market Size 2024-2029 ($ Millions)
Figure 83. GCC Countries Oncology Precision Medicine Market Size 2024-2029 ($ Millions)
Figure 84. Global Oncology Precision Medicine Market Size Market Share Forecast by Type (2024-2029)
Figure 85. Global Oncology Precision Medicine Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Oncology Precision Medicine Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Oncology Precision Medicine Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Oncology Precision Medicine Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Oncology Precision Medicine Sales Market Share by Country/Region (2022)
Figure 8. Oncology Precision Medicine Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Oncology Precision Medicine Market Size Market Share by Type in 2022
Figure 10. Oncology Precision Medicine in Breast Cancer
Figure 11. Global Oncology Precision Medicine Market: Breast Cancer (2018-2023) & ($ Millions)
Figure 12. Oncology Precision Medicine in Lung Cancer
Figure 13. Global Oncology Precision Medicine Market: Lung Cancer (2018-2023) & ($ Millions)
Figure 14. Oncology Precision Medicine in Colorectal Cancer
Figure 15. Global Oncology Precision Medicine Market: Colorectal Cancer (2018-2023) & ($ Millions)
Figure 16. Oncology Precision Medicine in Prostate Cancer
Figure 17. Global Oncology Precision Medicine Market: Prostate Cancer (2018-2023) & ($ Millions)
Figure 18. Oncology Precision Medicine in Cervical Cancer
Figure 19. Global Oncology Precision Medicine Market: Cervical Cancer (2018-2023) & ($ Millions)
Figure 20. Oncology Precision Medicine in Other Cancer
Figure 21. Global Oncology Precision Medicine Market: Other Cancer (2018-2023) & ($ Millions)
Figure 22. Global Oncology Precision Medicine Market Size Market Share by Application in 2022
Figure 23. Global Oncology Precision Medicine Revenue Market Share by Player in 2022
Figure 24. Global Oncology Precision Medicine Market Size Market Share by Regions (2018-2023)
Figure 25. Americas Oncology Precision Medicine Market Size 2018-2023 ($ Millions)
Figure 26. APAC Oncology Precision Medicine Market Size 2018-2023 ($ Millions)
Figure 27. Europe Oncology Precision Medicine Market Size 2018-2023 ($ Millions)
Figure 28. Middle East & Africa Oncology Precision Medicine Market Size 2018-2023 ($ Millions)
Figure 29. Americas Oncology Precision Medicine Value Market Share by Country in 2022
Figure 30. United States Oncology Precision Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 31. Canada Oncology Precision Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 32. Mexico Oncology Precision Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 33. Brazil Oncology Precision Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 34. APAC Oncology Precision Medicine Market Size Market Share by Region in 2022
Figure 35. APAC Oncology Precision Medicine Market Size Market Share by Type in 2022
Figure 36. APAC Oncology Precision Medicine Market Size Market Share by Application in 2022
Figure 37. China Oncology Precision Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 38. Japan Oncology Precision Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 39. Korea Oncology Precision Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 40. Southeast Asia Oncology Precision Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 41. India Oncology Precision Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 42. Australia Oncology Precision Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 43. Europe Oncology Precision Medicine Market Size Market Share by Country in 2022
Figure 44. Europe Oncology Precision Medicine Market Size Market Share by Type (2018-2023)
Figure 45. Europe Oncology Precision Medicine Market Size Market Share by Application (2018-2023)
Figure 46. Germany Oncology Precision Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 47. France Oncology Precision Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 48. UK Oncology Precision Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 49. Italy Oncology Precision Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 50. Russia Oncology Precision Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 51. Middle East & Africa Oncology Precision Medicine Market Size Market Share by Region (2018-2023)
Figure 52. Middle East & Africa Oncology Precision Medicine Market Size Market Share by Type (2018-2023)
Figure 53. Middle East & Africa Oncology Precision Medicine Market Size Market Share by Application (2018-2023)
Figure 54. Egypt Oncology Precision Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 55. South Africa Oncology Precision Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 56. Israel Oncology Precision Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 57. Turkey Oncology Precision Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 58. GCC Country Oncology Precision Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 59. Americas Oncology Precision Medicine Market Size 2024-2029 ($ Millions)
Figure 60. APAC Oncology Precision Medicine Market Size 2024-2029 ($ Millions)
Figure 61. Europe Oncology Precision Medicine Market Size 2024-2029 ($ Millions)
Figure 62. Middle East & Africa Oncology Precision Medicine Market Size 2024-2029 ($ Millions)
Figure 63. United States Oncology Precision Medicine Market Size 2024-2029 ($ Millions)
Figure 64. Canada Oncology Precision Medicine Market Size 2024-2029 ($ Millions)
Figure 65. Mexico Oncology Precision Medicine Market Size 2024-2029 ($ Millions)
Figure 66. Brazil Oncology Precision Medicine Market Size 2024-2029 ($ Millions)
Figure 67. China Oncology Precision Medicine Market Size 2024-2029 ($ Millions)
Figure 68. Japan Oncology Precision Medicine Market Size 2024-2029 ($ Millions)
Figure 69. Korea Oncology Precision Medicine Market Size 2024-2029 ($ Millions)
Figure 70. Southeast Asia Oncology Precision Medicine Market Size 2024-2029 ($ Millions)
Figure 71. India Oncology Precision Medicine Market Size 2024-2029 ($ Millions)
Figure 72. Australia Oncology Precision Medicine Market Size 2024-2029 ($ Millions)
Figure 73. Germany Oncology Precision Medicine Market Size 2024-2029 ($ Millions)
Figure 74. France Oncology Precision Medicine Market Size 2024-2029 ($ Millions)
Figure 75. UK Oncology Precision Medicine Market Size 2024-2029 ($ Millions)
Figure 76. Italy Oncology Precision Medicine Market Size 2024-2029 ($ Millions)
Figure 77. Russia Oncology Precision Medicine Market Size 2024-2029 ($ Millions)
Figure 78. Spain Oncology Precision Medicine Market Size 2024-2029 ($ Millions)
Figure 79. Egypt Oncology Precision Medicine Market Size 2024-2029 ($ Millions)
Figure 80. South Africa Oncology Precision Medicine Market Size 2024-2029 ($ Millions)
Figure 81. Israel Oncology Precision Medicine Market Size 2024-2029 ($ Millions)
Figure 82. Turkey Oncology Precision Medicine Market Size 2024-2029 ($ Millions)
Figure 83. GCC Countries Oncology Precision Medicine Market Size 2024-2029 ($ Millions)
Figure 84. Global Oncology Precision Medicine Market Size Market Share Forecast by Type (2024-2029)
Figure 85. Global Oncology Precision Medicine Market Size Market Share Forecast by Application (2024-2029)
